Insider Trading Alert - UVE, BPFH And RWLK Traded By Insiders

Yesterday, May 25, 2016, 98 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $88.32 to $137,937,966.40.

Highlighted Stocks Traded by Insiders:

Universal Insurance Holdings (UVE) - FREE Research Report

Downes Sean P, who is Ceo at Universal Insurance Holdings, bought 3,895 shares at $19.25 on May 25, 2016. Following this transaction, the Ceo owned 1.3 million shares meaning that the stake was boosted by 0.3% with the 3,895-share transaction.

The shares most recently traded at $19.68, up $0.43, or 2.18% since the insider transaction. Historical insider transactions for Universal Insurance Holdings go as follows:

  • 4-Week # shares bought: 6,500
  • 4-Week # shares sold: 20,000
  • 12-Week # shares bought: 6,500
  • 12-Week # shares sold: 20,000
  • 24-Week # shares bought: 6,500
  • 24-Week # shares sold: 20,000

The average volume for Universal Insurance Holdings has been 364,000 shares per day over the past 30 days. Universal Insurance Holdings has a market cap of $685.1 million and is part of the financial sector and insurance industry. Shares are down 17.64% year-to-date as of the close of trading on Wednesday.

Universal Insurance Holdings, Inc., through its subsidiaries, provides various property and casualty insurance products. The company primarily underwrites homeowners' insurance products; and offers reinsurance intermediary services. The stock currently has a dividend yield of 2.89%. The company has a P/E ratio of 6.3. Currently, there is 1 analyst who rates Universal Insurance Holdings a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on UVE - FREE

TheStreet Quant Ratings rates Universal Insurance Holdings as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, increase in net income and expanding profit margins. We feel its strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Universal Insurance Holdings Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Boston Private Financial Holdings (BPFH) - FREE Research Report

Higgins Martha, who is EVP, Chief HR Officer at Boston Private Financial Holdings, sold 10,000 shares at $12.42 on May 25, 2016. Following this transaction, the EVP, Chief HR Officer owned 50,340 shares meaning that the stake was reduced by 16.57% with the 10,000-share transaction.

The shares most recently traded at $12.50, up $0.08, or 0.64% since the insider transaction. Historical insider transactions for Boston Private Financial Holdings go as follows:

  • 4-Week # shares bought: 10,820
  • 4-Week # shares sold: 20,134
  • 12-Week # shares bought: 10,820
  • 12-Week # shares sold: 20,134
  • 24-Week # shares bought: 10,820
  • 24-Week # shares sold: 24,580

The average volume for Boston Private Financial Holdings has been 463,600 shares per day over the past 30 days. Boston Private Financial Holdings has a market cap of $1.0 billion and is part of the financial sector and banking industry. Shares are up 12.17% year-to-date as of the close of trading on Wednesday.

Boston Private Financial Holdings, Inc. operates as the bank holding company for Boston Private Bank & Trust Company that provides a range of banking services in the United States. The stock currently has a dividend yield of 3.22%. The company has a P/E ratio of 16.8. Currently, there is 1 analyst who rates Boston Private Financial Holdings a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BPFH - FREE

TheStreet Quant Ratings rates Boston Private Financial Holdings as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations and expanding profit margins. We feel its strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Boston Private Financial Holdings Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

ReWalk Robotics (RWLK) - FREE Research Report

SCP Vitalife Partners II LP, who is 10% Owner at ReWalk Robotics, sold 1,050 shares at $8.99 on May 25, 2016. Following this transaction, the 10% Owner owned 1.2 million shares meaning that the stake was reduced by 0.09% with the 1,050-share transaction.

SCP Vitalife Partners (Israel) II, L.P., who is 10% Owner at ReWalk Robotics, sold 350 shares at $8.99 on May 25, 2016. Following this transaction, the 10% Owner owned 401,105 shares meaning that the stake was reduced by 0.09% with the 350-share transaction.

The shares most recently traded at $8.60, down $0.39, or 4.57% since the insider transaction. Historical insider transactions for ReWalk Robotics go as follows:

  • 4-Week # shares sold: 16,148
  • 12-Week # shares sold: 16,148
  • 24-Week # shares sold: 66,148

The average volume for ReWalk Robotics has been 78,400 shares per day over the past 30 days. ReWalk Robotics has a market cap of $107.6 million and is part of the health care sector and health services industry. Shares are down 39.88% year-to-date as of the close of trading on Wednesday.

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes exoskeletons for wheelchair-bound individuals. Currently, there is 1 analyst who rates ReWalk Robotics a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on RWLK - FREE

TheStreet Quant Ratings rates ReWalk Robotics as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, weak operating cash flow, poor profit margins, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share. Get the full ReWalk Robotics Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

Soaring Nickel Prices Could Be Bad News for Electric Carmakers Like Tesla

Soaring Nickel Prices Could Be Bad News for Electric Carmakers Like Tesla

Let the Najarian Brothers Help You Generate Income With Options

Let the Najarian Brothers Help You Generate Income With Options

Oil Stocks Jump as Global Crude Oil Rally Gains Steam

Oil Stocks Jump as Global Crude Oil Rally Gains Steam

P&G Tops Forecasts in Early Q3 Earnings Release Following Merck KGaA Deal

P&G Tops Forecasts in Early Q3 Earnings Release Following Merck KGaA Deal

Amazon Prime Tops 100 Million Members and 4 Other Stories You Must Know Thursday

Amazon Prime Tops 100 Million Members and 4 Other Stories You Must Know Thursday